News & Publications
Stanford Medicine News: Cancer
-
Quest to find better treatments for rare blood cancer leads to new therapies
Hematologist Jason Gotlib wanted more effective treatments for patients with systemic mastocytosis. His research has led to the approval of two new treatments by the Food and Drug Administration.
-
Scientists find long-elusive structure of key cellular-signaling molecule
The structure of a critical cellular-signaling molecule has finally been discovered by Stanford researchers. The finding may lead to new therapies.
-
Cancer drugs might be able to target tuberculosis, study finds
Tuberculosis lesions in the lungs have high levels of proteins that suppress the immune system. Cancer drugs that target these proteins could be used to fight the bacterial infection.
-
Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds
Rituximab, a drug widely used in patients with lymphoma, blunts or eliminates the antibody response to COVID-19 vaccines if it is administered before them, Stanford researchers say.
Media Relations
The Office of Communication & Public Affairs is dedicated to sharing School of Medicine news with the media and helping journalists secure expert interviews, photographs and rich media for stories on medicine and health care.
